OpenURL Connection Search

Select item for more details and to access through your institution.

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
Published in:
2017
By:
- Ubink, I.;
- Bloemenda, H. J.;
- Elias, S. G.;
- Brink, M. A.;
- Schwartz, M. P.;
- Holierhoek, Y. C. W.;
- Verheijen, P. M.;
- Boerman, A. W.;
- Mathijssen, R. H. J.;
- de Leng, W. W. J.;
- de Weger, R. A.;
- van Grevenstein, W. M. U.;
- Koopman, M.;
- Lolkema, M. P.;
- Kranenburg, O.;
- Borel Rinkes, I. H. M.;
- Bloemendal, H J
Publication type:
journal article
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.
Published in:
PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0293264
By:
- Heine, R. J. S. D.;
- Thielen, F. W.;
- Mathijssen, R. H. J.;
- van Leeuwen, R. W. F.;
- Franken, M. G.;
- Uyl-de Groot, C. A.
Publication type:
Article
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
Published in:
Oncogene, 2013, v. 32, n. 36, p. 4284, doi. 10.1038/onc.2012.433
By:
- van Jaarsveld, M T M;
- Helleman, J;
- Boersma, A W M;
- van Kuijk, P F;
- van IJcken, W F;
- Despierre, E;
- Vergote, I;
- Mathijssen, R H J;
- Berns, E M J J;
- Verweij, J;
- Pothof, J;
- Wiemer, E A C
Publication type:
Article
Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2.
Published in:
Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 6, p. 816, doi. 10.1038/clpt.2011.42
By:
- Eechoute, K.;
- Franke, R. M.;
- Loos, W. J.;
- Scherkenbach, L. A.;
- Boere, I.;
- Verweij, J.;
- Gurney, H.;
- Kim, R. B.;
- Tirona, R. G.;
- Mathijssen, R. H. J.;
- Sparreboom, A.
Publication type:
Article
Influence of Lean Body Weight on Anticancer Drug Clearance.
Published in:
2009
By:
- Mathijssen, R. H. J.;
- Sparreboom, A.
Publication type:
Letter
Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition.
Published in:
Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.627186
By:
- de Joode, K.;
- Oostvogels, A. A. M.;
- GeurtsvanKessel, C. H.;
- de Vries, R. D.;
- Mathijssen, R. H. J.;
- Debets, R.;
- van der Veldt, A. A. M.
Publication type:
Article
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
Published in:
2017
By:
- Hu, S;
- Mathijssen, R H J;
- de Bruijn, P;
- Baker, S D;
- Sparreboom, A
Publication type:
corrected article
Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer.
Published in:
British Journal of Cancer, 2017, v. 116, n. 10, p. 1312, doi. 10.1038/bjc.2017.91
By:
- Janssen, A;
- Verkleij, C P M;
- van der Vlist, A;
- Mathijssen, R H J;
- Bloemendal, H J;
- ter Heine, R
Publication type:
Article
Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer.
Published in:
2017
By:
- Janssen, A;
- Verkleij, C P M;
- van der Vlist, A;
- Mathijssen, R H J;
- Bloemendal, H J;
- Ter Heine, R
Publication type:
journal article
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors.
Published in:
British Journal of Cancer, 2015, v. 112, n. 6, p. 1011, doi. 10.1038/bjc.2015.82
By:
- Kloth, J S L;
- Pagani, A;
- Verboom, M C;
- Malovini, A;
- Napolitano, C;
- Kruit, W H J;
- Sleijfer, S;
- Steeghs, N;
- Zambelli, A;
- Mathijssen, R H J
Publication type:
Article
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors.
Published in:
2015
By:
- Kloth, J S L;
- Pagani, A;
- Verboom, M C;
- Malovini, A;
- Napolitano, C;
- Kruit, W H J;
- Sleijfer, S;
- Steeghs, N;
- Zambelli, A;
- Mathijssen, R H J
Publication type:
journal article
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2014, v. 110, n. 10, p. 2441, doi. 10.1038/bjc.2014.194
By:
- Lankheet, N A G;
- Kloth, J S L;
- Gadellaa-van Hooijdonk, C G M;
- Cirkel, G A;
- Mathijssen, R H J;
- Lolkema, M P J K;
- Schellens, J H M;
- Voest, E E;
- Sleijfer, S;
- de Jonge, M J A;
- Haanen, J B A G;
- Beijnen, J H;
- Huitema, A D R;
- Steeghs, N
Publication type:
Article
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
Published in:
British Journal of Cancer, 2014, v. 110, n. 4, p. 894, doi. 10.1038/bjc.2013.811
By:
- Hu, S;
- Mathijssen, R H J;
- de Bruijn, P;
- Baker, S D;
- Sparreboom, A
Publication type:
Article
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Published in:
2013
By:
- Gits, C M M;
- van Kuijk, P F;
- Jonkers, M B E;
- Boersma, A W M;
- van Ijcken, W F;
- Wozniak, A;
- Sciot, R;
- Rutkowski, P;
- Schöffski, P;
- Taguchi, T;
- Mathijssen, R H J;
- Verweij, J;
- Sleijfer, S;
- Debiec-Rychter, M;
- Wiemer, E A C
Publication type:
journal article
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Published in:
British Journal of Cancer, 2013, v. 109, n. 6, p. 1625, doi. 10.1038/bjc.2013.483
By:
- Gits, C M M;
- van Kuijk, P F;
- Jonkers, M B E;
- Boersma, A W M;
- van IJcken, W F;
- Wozniak, A;
- Sciot, R;
- Rutkowski, P;
- Schöffski, P;
- Taguchi, T;
- Mathijssen, R H J;
- Verweij, J;
- Sleijfer, S;
- Debiec-Rychter, M;
- Wiemer, E A C
Publication type:
Article
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.
Published in:
British Journal of Cancer, 2013, v. 108, n. 5, p. 1071, doi. 10.1038/bjc.2013.48
By:
- van Leeuwen, R W F;
- Brundel, D H S;
- Neef, C;
- van Gelder, T;
- Mathijssen, R H J;
- Burger, D M;
- Jansman, F G A
Publication type:
Article
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.
Published in:
2010
By:
- Lammers, L. A.;
- Mathijssen, R. H. J.;
- van Gelder, T.;
- Bijl, M. J.;
- de Graan, A-J. M.;
- Seynaeve, C.;
- van Fessem, M. A.;
- Berns, E. M.;
- Vulto, A. G.;
- van Schaik, R. H. N.
Publication type:
journal article
Myelosuppression by sunitinib is flt-3 genotype dependent.
Published in:
2010
By:
- van Erp, N. P.;
- Mathijssen, R. H. J.;
- van der Veldt, A. A.;
- Haanen, J. B.;
- Reyners, A. K. L.;
- Eechoute, K;
- Boven, E;
- Wessels, J. A. M.;
- Guchelaar, H-J;
- Gelderblom, H
Publication type:
Letter
Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 1, p. 81, doi. 10.1038/clpt.2014.47
By:
- Diekstra, M H M;
- Klümpen, H J;
- Lolkema, M P J K;
- Yu, H;
- Kloth, J S L;
- Gelderblom, H;
- Schaik, R H N;
- Gurney, H;
- Swen, J J;
- Huitema, A D R;
- Steeghs, N;
- Mathijssen, R H J
Publication type:
Article
Conventional Dosing of Anticancer Agents: Precisely Wrong or Just Inaccurate?
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 361, doi. 10.1038/clpt.2014.12
By:
- Bins, S;
- Ratain, M J;
- Mathijssen, R H J
Publication type:
Article
Doubt About the Feasibility of Preemptive Genotyping.
Published in:
Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 3, p. 233, doi. 10.1038/clpt.2012.191
By:
- Koch, B C P;
- Schaik, R H N;
- Gelder, T;
- Mathijssen, R H J
Publication type:
Article
OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 642, doi. 10.1038/clpt.2012.106
By:
- Lancaster, C S;
- Bruun, G H;
- Peer, C J;
- Mikkelsen, T S;
- Corydon, T J;
- Gibson, A A;
- Hu, S;
- Orwick, S J;
- Mathijssen, R H J;
- Figg, W D;
- Baker, S D;
- Sparreboom, A
Publication type:
Article
Individualization of Tamoxifen Treatment for Breast Carcinoma.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 4, p. 431, doi. 10.1038/clpt.2012.94
By:
- Binkhorst, L;
- van Gelder, T;
- Mathijssen, R H J
Publication type:
Article
Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 4, p. 503, doi. 10.1038/clpt.2012.136
By:
- Eechoute, K;
- van der Veldt, A A M;
- Oosting, S;
- Kappers, M H W;
- Wessels, J A M;
- Gelderblom, H;
- Guchelaar, H-J;
- Reyners, A K L;
- van Herpen, C M L;
- Haanen, J B;
- Mathijssen, R H J;
- Boven, E
Publication type:
Article
Effects of CYP Induction by Rifampicin on Tamoxifen Exposure.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 1, p. 62, doi. 10.1038/clpt.2011.372
By:
- Binkhorst, L;
- van Gelder, T;
- Loos, W J;
- de Jongh, F E;
- Hamberg, P;
- Moghaddam-Helmantel, I M Ghobadi;
- de Jonge, E;
- Jager, A;
- Seynaeve, C;
- van Schaik, R H N;
- Verweij, J;
- Mathijssen, R H J
Publication type:
Article
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 5, p. 673, doi. 10.1007/s00280-006-0221-x
By:
- Felici, A.;
- Loos, W. J.;
- Verweij, J.;
- Cirillo, I.;
- de Bruijn, P.;
- Nooter, K.;
- Mathijssen, R. H. J.;
- de Jonge, M. J. A.
Publication type:
Article
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Published in:
2010
By:
- Burger, H;
- Zoumaro-Djayoon, A;
- Boersma, AWM;
- Helleman, J;
- Berns, EMJJ;
- Mathijssen, RHJ;
- Loos, WJ;
- Wiemer, EAC;
- Boersma, A W M;
- Berns, E M J J;
- Mathijssen, R H J;
- Loos, W J;
- Wiemer, E A C
Publication type:
journal article
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor.
Published in:
2004
By:
- Sparreboom, A.;
- Kehrer, D. F. S.;
- Mathijssen, R. H. J.;
- Xie, R.;
- de Jonge, M. J. A.;
- de Bruijn, P.;
- Planting, A. S. T.;
- Eskens, F. A. L. M.;
- Verheij, C.;
- de Heus, G.;
- Klaren, A.;
- Zhang, S.;
- Verhaeghe, T.;
- Palmer, P. A.;
- Verweij, J.
Publication type:
journal article
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37764-z
By:
- de Joode, K.;
- van de Geer, W. S.;
- van Leenders, G. J. L. H.;
- Hamberg, P.;
- Westgeest, H. M.;
- Beeker, A.;
- Oosting, S. F.;
- van Rooijen, J. M.;
- Beerepoot, L. V.;
- Labots, M.;
- Mathijssen, R. H. J.;
- Lolkema, M. P.;
- Cuppen, E.;
- Sleijfer, S.;
- van de Werken, H. J. G.;
- van der Veldt, A. A. M.
Publication type:
Article

Found: 29